Digital diet plan aims to boost heart pumping power after heart attack

NCT ID NCT07427199

Recruiting now Disease control Sponsor: Saglik Bilimleri Universitesi Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a personalized nutrition program, supported by digital tools like meal plans and remote guidance, can improve heart function in people who recently had a severe heart attack (STEMI). Two hundred participants will follow the program for three months, and doctors will measure their heart's pumping ability at the start, one month, and three months. The goal is to see if better nutrition can help the heart recover more effectively.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: digital content-supported medical nutrition therapy
What this could lead to: If it works, this could point toward a simple, low-cost way to help heart attack patients recover better heart function through diet.
What could go wrong: This is a small, early-stage trial with only 200 people. The nutrition program is short (3 months), so any benefits may be modest or not last long. Diet changes can be hard to stick with.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ST-ELEVATION MYOCARDIAL INFARCTION (STEMI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ST-elevation myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ST-ELEVATION MYOCARDIAL INFARCTION (STEMI)

Contacts and locations

Locations

Ondokuz Mayıs Üniversitesi Tıp Fakültesi Hastanesi
RECRUITING

Samsun, Atakum, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.